Wednesday, June 12, 2013

The display and use of drug information on this site is subject to express terms of use (click here). By continuing to view the drug information, you agree to abide such terms of use.

Promacta Oral Uses and How to Use


IMPORTANT NOTE: The following information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that use of the drug is safe, appropriate or effective for you. Consult your healthcare professional before using this drug.

Generic Name: ELTROMBOPAG - ORAL
Pronounced: (el-TROM-boe-pag)

Promacta Oral Uses

This medication is used to treat a certain blood disorder (idiopathic thrombocytopenia purpura - ITP) in which the blood does not clot properly due to a lack of platelets. Platelets are a type of blood cell needed to form blood clots and prevent bleeding. Eltrombopag decreases your risk of bleeding by increasing the number of platelets. Eltrombopag acts like a certain natural substance (thrombopoietin) that causes the body to produce platelets.

How To Use Promacta Oral

Read the Medication Guide provided by your pharmacist before you start using eltrombopag and each time you get a refill. If you have any questions, consult your doctor or pharmacist.

Only patients enrolled in the PROMACTA CARES program may obtain and use eltrombopag. After talking with your doctor about the risks and benefits of treatment, you will need to sign an enrollment form at your doctor's office before receiving your first prescription. Consult your doctor or pharmacist for more details about the PROMACTA CARES program and for more information about the risks and benefits of using this medication.

Take this medication by mouth, usually once daily or as directed by your doctor. Take on an empty stomach, either 1 hour before a meal or 2 hours after a meal.

Take this medication at least 4 hours before or after taking any products that contain magnesium, aluminum, or calcium. Some examples include antacids, vitamins/minerals, quinapril, certain forms of didanosine (chewable/dispersible buffered tablets or pediatric oral solution), and sucralfate. Follow the same instructions with dairy products (such as milk, yogurt), calcium-enriched juice, bismuth subsalicylate, iron, selenium, and zinc. These products bind with eltrombopag, preventing its full absorption.

Take this medication regularly to get the most benefit from it. To help you remember, take it at the same time each day. Dosage is based on your medical condition and response to treatment. Do not take more than 75 milligrams a day. Your doctor will order blood tests (platelet counts) to find the right dose for you. Keep all medical/lab appointments. Follow your doctor's directions carefully. If you are of Asian descent or if you have liver problems, your doctor may direct you to start with a lower dose because you may be more sensitive to its effects.

Your risk of bleeding may increase when you stop using eltrombopag. After your last dose, your doctor should order a blood test once a week for at least 4 weeks to check for bleeding problems. Tell your doctor immediately if you develop any bleeding/bruising.

Ask your doctor if you should continue taking your other medications for ITP (such as corticosteroids, azathioprine, danazol) while you are using eltrombopag.

Tell your doctor if your condition (bleeding/bruising) persists or worsens.



CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.
Information last revised October 2010 Copyright(c) 2010 First DataBank, Inc.